(Q38859608)
Statements
AKT Antagonist AZD5363 Influences Estrogen Receptor Function in Endocrine-Resistant Breast Cancer and Synergizes with Fulvestrant (ICI182780) In Vivo (English)
Stephanie K Guest
Qiong Gao
Nikiana Simigdala
Urszula M Polanska
Hayley Campbell
Gianmaria Liccardi
Stephen Johnston
Barry R Davies
Lesley-Ann Martin
Mitch Dowsett
26 June 2015